HEE-JIN JANG to Neoadjuvant Therapy
This is a "connection" page, showing publications HEE-JIN JANG has written about Neoadjuvant Therapy.
Connection Strength
0.090
-
Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2026 Aug; 172(2):433-449.e10.
Score: 0.050
-
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2023 02 01; 29(3):548-559.
Score: 0.040